Skip to main content
Cancer Immunology, Immunotherapy : CII logoLink to Cancer Immunology, Immunotherapy : CII
. 1997 May;44(2):70–76. doi: 10.1007/s002620050357

Role of perforin, granzymes and the proliferative state of the target cells in apoptosis and necrosis mediated by bispecific-antibody-activated cytotoxic T cells

C Renner 1, Gerhard Held 1, Sascha Ohnesorge 1, Stefan Bauer 1, Klaus Gerlach 1, Jan-Peter Pfitzenmeier 1, Michael Pfreundschuh 1
PMCID: PMC11037813  PMID: 9177467

Abstract

 Bispecific monoclonal antibodies (bi-mAb), directed against a tumor-associated antigen and the CD3 or CD28 antigen on T lymphocytes, induce activation of resting T lymphocytes and target-specific tumor cell lysis. We now show that both necrosis and apoptosis contribute to T-cell-mediated tumor cell destruction. Even though T cells up-regulate FAS/APO-1 expression upon bi-mAb stimulation, FAS/APO-1-mediated apoptosis does not contribute to bi-mAb-mediated destruction of Hodgkin’s cells. CD8+ lymphocytes were the most potent effectors of bi-mAb-mediated cytotoxicity and had the highest levels of mRNA coding for perforin and granzyme A and B. Ca2+-complexing agents, which abrogate perforin activity, led to decreased levels of necrosis, while inhibition of granzyme activity in effector or target cells had a similar effect on apoptosis. Granzyme-mediated apoptosis critically dependent on the proliferative state of the target cells, while perforin-induced necrosis was not cell-cycle-dependent. Our results underline the importance of the expression levels of perforin and granzymes in the effector T cells and of the proliferative state of the target cells in bi-mAb-mediated apoptosis and necrosis of tumor cells.

Keywords: Key words Hodgkin’s lymphoma, Bispecific antibodies, T lymphocytes, Perforin, Granzymes

Footnotes

Received: 5 December 1996 / Accepted: 16 January 1997


Articles from Cancer Immunology, Immunotherapy : CII are provided here courtesy of Springer

RESOURCES